Dantrolene Sodium and Prevnar Intramuscular

• Generic Name: dantrolene
• Dosage Forms: n.a.
• Other Brand Names: Dantrium, Dantrium Intravenous, Revonto, Ryanodex

Used orally for management of spasticity resulting from upper motor neuron disorders (e.g., multiple sclerosis, cerebral palsy, spinal cord injury, stroke syndrome).

Evidence supporting use is limited and the drug is associated with many adverse effects, some of which may be severe (e.g., hepatotoxicity); however, subtle but meaningful improvement (e.g., decrease in severity of spasticity, ability to resume daily function) may occasionally occur in some patients.

Ineffective in the treatment of amyotrophic lateral sclerosis (ALS).

Not indicated for the treatment of muscle spasms resulting from rheumatic disorders or musculoskeletal trauma.

IV treatment of fulminant hypermetabolism of skeletal muscle that is characteristic of malignant hyperthermia crisis; should be used with and not as a substitute for supportive measures (e.g., oxygen, treatment of metabolic acidosis, cooling procedures).

Dantrolene sodium for injectable suspension (Ryanodex) is designated an orphan drug by FDA for this use.

Also has been used preoperatively to prevent or attenuate the development of malignant hyperthermia in susceptible individuals; however, prophylactic use no longer recommended because of adverse effects and questionable benefit.

Has been used for the treatment of neuroleptic malignant syndrome; fatalities reported despite therapy with the drug.

• Generic Name: pneumococcal 13-valent vaccine
• Dosage Forms: n.a.
• Other Brand Names: Prevnar 13

Pneumococcal 13-valent diphtheria conjugate vaccine is an active immunizing agent used to prevent infection by pneumococcal bacteria. It works by causing your body to produce its own protection (antibodies) against the disease.

Pneumococcal infection can cause serious problems, such as pneumonia, which affects the lungs; meningitis, which affects the brain; and bacteremia, which is a severe infection in the blood. Pneumococcal infection is also an important cause of ear infections in children.

Unless otherwise contraindicated, immunization (vaccination) against pneumococcal disease is recommended for infants and young children 6 weeks to 5 years of age (prior to the 6th birthday), children 6 to 17 years of age (prior to the 18th birthday), or to adults 18 years of age and older.

For infants and young children, immunization requires 1 to 4 doses of the vaccine, depending on the age at the first dose. This vaccine can be given at the same time as other routine vaccinations.

This vaccine is to be given only by or under the supervision of your doctor.